Zimbabwe has turned down a significant US health deal worth 367 million US dollars (272 million pounds) spanning five years because of the United States' request for sensitive information.
The decision came to light following a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government representative has since explained that the US was requesting health data for research and commercial purposes while was unwilling to share the benefits from any future vaccines.
"We must now begin the difficult and regrettable process of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had provided over $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged further negotiations to find a agreement agreeable to all parties so the nation's vital HIV programme can be sustained.
Broader Implications
This development comes after a comparable situation in neighbouring Kenya, where a high court suspended a related deal with the US following concerns were filed about the safety of Kenyans' medical information.
After returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost openness and responsibility.
Based on statements, 16 nations in Africa have to date agreed to these new health pacts, constituting more than $18.3bn of fresh investment.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy through American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to surrender its genetic material and health information for a long time, with no equivalent guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Put simply, our nation would provide the basic resources for medical research without any certainty that the end products would be accessible to our people if a future health crisis arise."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting frameworks previously set up via the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.
"This mechanism is designed to guarantee that when a country contributes its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage ongoing discussions with our American counterparts on how future collaboration could be designed in a manner that respects the independence and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but urged that talks should continue since much of the nation's Aids initiatives depended on foreign aid.
"If technical issues exist, including those relating to information security or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," the group commented.
The situation underscores the complex challenges between accepting vital international aid and safeguarding national sovereignty in an increasingly data-driven world.